Patent classifications
C08G65/3324
HYPOCRELLIN DERIVATIVE SUBSTITUTED BOTH IN A PERI-POSITION AND IN 2-POSITION BY AMINO, PREPARATION METHOD, AND APPLICATION THEREOF
The present invention discloses a hypocrellin derivative substituted both in a peri-position and in a 2-position by an amino, and a preparation method and use thereof. A general structural formula of the derivative is as represented by formulas I-a to I-d:
##STR00001##
The hypocrellin derivative substituted both in a peri-position and in a 2-position by an amino prepared in the present invention has a maximum absorption wavelength of 600-650 nm and a molar extinction coefficient reaching about 20000-40000 M.sup.−1cm.sup.−1. Compared with unmodified hypocrellin or hypocrellin having only a 2-position modified, an absorption spectrum of the derivative is significantly red-shifted and the molar extinction coefficient is greatly improved, and the derivative can efficiently produce reactive oxygen species such as singlet oxygen in a photosensitive condition. In the same condition, the hypocrellin derivative substituted both in a peri-position and in a 2-position by an amino involved in the present invention, when used as a photosensitizer, has a stronger ability to photo-dynamically inactivate tumor cells than the first and second generation commercial photosensitizers.
PROTEIN-POLYMER-DRUG CONJUGATES
A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -L.sup.D-D, the protein based recognition-molecule being connected to the polymeric carrier by L.sup.P. Each occurrence of D is independently a therapeutic agent having a molecular weight ≤5 kDa. L.sup.D and L.sup.P are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.
COMPOUND, WATER-BORNE EPOXY RESIN COMPOSITION COMPRISING THE SAME, AND COATING COMPOSITION COMPRISING THE WATER-BORNE EPOXY RESIN COMPOSITION
The present invention provides a compound comprising EO (ethylene oxide)/PO (propylene oxide) block copolymer which can be used as an emulsifier. The present invention also provides a water-borne epoxy resin composition comprising the compound and a coating composition comprising the water-borne epoxy resin composition. The advantages of the present invention is that the epoxy resin composition or the coating composition, which the compound of the present invention is added to, enhances the compatibility between water and epoxy resin, and enhances the anticorrosive properties of the epoxy resin composition and the coating composition.
NITRILE OXIDE COMPOUND
The present invention provides a compound represented by formula (I) wherein symbols in the formula are as defined in the specification.
##STR00001##
RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME
In some aspects, the present disclosure pertains to a polymer that comprises a plurality of polymeric arms, wherein a first portion of the polymeric arms each comprises a reactive end group and wherein a second portion of the polymeric arms each comprises a radiopaque aromatic moiety comprising a monocyclic or multicyclic aromatic structure having a plurality of radiopaque functional groups and a plurality of hydrophilic functional groups. In some aspects, the present disclosure pertains to systems comprising (a) a first composition comprising such a radiopaque polymer and (b) a second composition comprising a multifunctional compound that comprises reactive functional groups that are reactive with the reactive end group. In some aspects, the present disclosure pertains to crosslinked reaction products of (a) such a radiopaque polymer and (b) a multifunctional compound that comprises reactive functional groups that are reactive with the reactive end group.
Fullerene derivative and lubricant
One embodiment of the present invention is a fullerene derivative represented by general formula (1) ##STR00001##
(wherein FLN is a fullerene backbone; each A is independently a monovalent group including a divalent perfluoropolyether group; each R is each independently a hydrogen atom, a hydrocarbon group, or an alkoxycarbonyl group including a divalent perfluoropolyether group; at least one of the 2m R is a hydrocarbon group or an alkoxycarbonyl group including a divalent perfluoropolyether group; m is an integer from 1 to 5; and n is an integer from 1 to 6).
Protein-polymer-drug conjugates
A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -L.sup.D-D, the protein based recognition-molecule being connected to the polymeric carrier by L.sup.P. Each occurrence of D is independently a therapeutic agent having a molecular weight5 kDa. L.sup.D and L.sup.P are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.
MULTI-ARM POLYMER PRODRUGS
Provided herein are water-soluble prodrugs, compositions comprising such prodrugs, and related methods of making and administering the same. The prodrugs of the invention comprise a water-soluble polymer having three or more arms, at least three of which are typically covalently attached to an active agent, e.g., a small molecule. The conjugates of the invention provide an optimal balance of polymer size and structure for achieving improved drug loading, since the conjugates of the invention possess three or more active agents releasably attached to a multi-armed water-soluble polymer. The prodrugs of the invention are therapeutically effective, and exhibit improved properties in-vivo when compared to unmodified parent drug.
POLYPHENYLENE ETHER BISMALEIMIDE RESIN
A polyphenylene ether bismaleimide resin is provided. The polyphenylene ether bismaleimide resin (PPE-BMI) is formed from a modified polyphenylene ether diamine and a maleic anhydride by a condensation polymerization. The modified polyphenylene ether diamine is formed by reacting a phenol-based compound with a polyphenylene ether.
SYNTHESIS OF PEG-BASED THIOL-NORBORNENE HYDROGELS WITH TUNABLE HYDROYLITIC DEGRADATION PROPERTIES
Methods for synthesizing a hydrogel having tunable hydrolylic degradation kinetics according to certain embodiments include synthesizing a norborene-functionalized polyethylene glycol macromer having an ester linkage between a polyethylene glycol domain of the macromer and a norbornene domain of the macromer and having a carboxyl group on the norbornene; and reacting a quantity of such macromers with a quantity of dithiol molecules by an ultraviolet-initiated photo-gelation reaction to yield a hydrogel. Such macromers and such hydrogels form additional aspects of the disclosure, as do a wide variety of methods for tuning and for using such hydrogels.